Chronic treatment with antidepressants, verapamil, or lithium inhibits the serotonin-induced intracellular calcium response in individual C6 rat glioma cells

Life Sciences

Volumn 60, Issue 11, 1997, Pages 817-823

  Yamaji, T ^a   Kagaya, A ^a   Uchitomi, Y ^b   Yokota, N ^a   Yamawaki, S ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

affective disorders; antidepressants; intracellular Ca2+ mobilization; lithium; serotonin; verapamil

Indexed keywords

ANTIDEPRESSANT AGENT; CALCIUM; CALCIUM ANTAGONIST; CITALOPRAM; CLOMIPRAMINE; FURA 2; FURA 2 ACETOXYMETHYL ESTER; LITHIUM; SEROTONIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; GLIOMA CELL; IMAGING; LONG TERM EXPOSURE; MICROSCOPY; NONHUMAN; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CITALOPRAM; CLOMIPRAMINE; DRUG INTERACTIONS; GLIOMA; INTRACELLULAR FLUID; LITHIUM CHLORIDE; RATS; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TUMOR CELLS, CULTURED; VERAPAMIL;

ANIMALIA;

EID: 0031557111     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00010-6     Document Type: Article

References (45)

1. 1. S. AVISSAR and G. SCHREIBER, Biol. Psychiatry 31 435-459 (1992).
2. 2. G. SCHREIBER, S. AVISSAR, A. DANON and R.H. BELMAKER, Biol. Psychiatry 29 273-280 (1991).
3. 3. L.T. YOUNG, P.P. LI, S.J. KISH, K.P. SIU, A. KAMBLE, O. HORNYKIEWICZ and J.J. WARSH, J. Neurochem. 61 890-898 (1993).
4. 4. H.K. MANJI, G. CHEN, H. SHIMON, J.K. HSIAO, W.Z. POTTER and R.H. BELMAKER, Arch. Gen. Psychiatry 52 135-144 (1995).
5. 5. E. FRIEDMAN, H.Y. WANG, D. LEVINSON, T.A. CONNELL and H. SINGH, Biol. Psychiatry 33 520-525 (1993).
6. 6. S.L. DUBOVSKY, J. CHRISTIANO, L.C. DANIELL, R.D. FRANKS, J. MURPHY, L. ADLER, N. BAKER and A. HARRIS, Arch. Gen. Psychiatry 46 632-638 (1989).
7. 7. I. KUSUMI, T. KOYAMA and I. YAMASHITA, Biol. Psychiatry 30 310-312 (1993).
8. 8. M. MIKUNI, A. KAGAYA, K. TAKAHASHI and H.Y. MELTZER, Psychopharmacol. 106 311-314 (1992).
9. 9. S.L. DUBOVSKY, J. MURPHY, M. THOMAS and J. RADEMACHER, Am. J. Psychiatry 149 118-120 (1992).
10. 10. A. ECKERT, H. GANN, D. RIEMANN, J. ALDENHOFF and W.E. MULLER, Biol. Psychiatry 34 565-568 (1993).
11. 11. Y. OKAMOTO, A. KAGAYA, H. SHINNO, N. MOTOHASHI and S. YAMAWAKI, Life Sci. 56 327-332 (1995).
12. 12. S. YAMAWAKI, A. KAGAYA, Y. OKAMOTO, Y. UCHITOMI, M. SHIMIZU and A. NISHIDA, Int. Acad. Biomed. Drug Res. Racagni and Shibuya (Eds), Karger, Basel vol. 11 pp. 106-115 (1996).
13. 13. R.S. JOPE, L. SONG and K. KOLASA, Biol. Psychiatry 31 505-514 (1992).
14. 14. K.P. LESCH, C.S. AULAKH, T.J. TOLLIVER, J.L. HILL and D.L. MURPHY, Eur. J. Pharmacol. 207 361-364 (1991).
15. 15. P.P. LI, T. YOUNG, Y.K. TAM, D. SIBONY and J.J. WARSH, Biol. Psychiatry 34 162-170 (1993).
16. 16. Y. OKAMOTO, A. KAGAYA, N. MOTOHASHI and S. YAMAWAKl, Neurochem. Int. 26 233-238 (1995).
17. 17. H. OZAWA and M.M. RASENICK, Mol. Pharmacol. 36 803-808 (1989).
18. 18. H. YAMAMOTO, U. TOMITA, M. MIKUNI, I. KOBAYASHI, A. KAGAYA, T. KATADA, M. UI and K. TAKAHASHI, Neurosci. Lett. 139 194-196 (1992).
19. 19. M. SHIMIZU, A. NISHIDA and S. YAMAWAKI, J. Neurochem. 60 595-601 (1993).
20. 20. M. SHIMIZU, A. NISHIDA, H. FUKUDA, H. SAITO and S. YAMAWAKI, Eur. J. Pharmacol. 268 65-71 (1994).
21. 21. T. YAMAJI, A. KAGAYA, Y. OKAMOTO, T. HAYASHI, N. MOTOHASHI and S. YAMAWAKI, Neuropsychobiol. 33 55-59 (1996).
22. 22. S.L. DUBOVSKY, R.D. FRANKS, M.L. LIFSCHITZ and P. COHEN, Am. J. Psychiat. 139 502-504 (1982).
23. 23. S.L. DUBOVSKY, R.D. FRANKS, S. ALLEN and J. MURPHY, Psychiat. Res. 18 309-320 (1986).
24. 24. A.J. GIANNINI, W.L. HOUSER, R.H. LOISELLE, M.C. GIANNINI and W.A. PRICE, Am. J. Psychiatry 141 1602-1603 (1984).
25. 25. I. OSWALD, V. BREGINOVA and D.L.F. DUNLEAVY, Br. J. Psychiatry 120 673-67 (1972).
26. 26. S.B. FREEDMAN, D.R. RICHMOND, J.J. ASHLEY and D.T. KELLY, Clin. Pharmacol. Ther. 30 644-652 (1981).
27. 27. A. NAGY and R. JOHANSSON, Psychopharmacol. 54 125-131 (1977).
28. 28. D. DING, M. TOTH, C. PARKS, B. HOFFMAN and T. SHENK, Mol. Brain Res. 20 181-191 (1993).
29. 29. D. MANOR, N. MORAN and M. SEGAL, Glia 6 118-126 (1992).
30. 30. S. MURAOKA, M. MIKUNI, A. KAGAYA, K. SAITOH and K. TAKAHASHI, Neuroendocrinology 57 322-329 (1993).
31. 31. R.C. ARORA and H.Y. MELTZER, Life Sci 44 725-734 (1989).
32. 32. M. MIKUNI, I. KUSUMI, A. KAGAYA, Y. KURODA, H. MORI and K. TAKAHASHI, Prog. Neuropsychopharmacol. Biol. Psychiat. 15 49-61 (1991).
33. 33. P.H. FISHMAN and J.P.M. FINBERG, J. Neurochem. 49 282-289(1987).
34. 34. U. LELI and G. HAUSER, Biochem. Pharmacol. 36 31-37 (1987).
35. 35. M. BERK, W. BODEMER, T. VAN OUDENHOVE and N. BUTKOW, Human Psychopharmacol. 10 189-193 (1995).
36. 36. Y. CHENG, L. PENG and L. HERTZ, Can. J. Physiol. Pharmacol. 72. Suppl.1 440 (1994).
37. 37. A. KAGAYA, A. KUGAYA, T. HAYASHI, Y. OKAMOTO, M. TAKEBAYASHI, Y. UCHITOMI and S. YAMAWAKI, Prog. Neuro-Psychopharmacol. Biol. Psychiat. 20 157-166 (1996).
38. 38. A. KAGAYA, M. MIKUNI, S. MURAOKA and K. TAKAHASHI, Jpn. J. Psychiat. Neurol. 46 569 (1992).
39. 39. A. KAGAYA, M. MIKUNI, S. MURAOKA, K. SAITOH, T. OGAWA, H. SHINNO, S. YAMAWAKI and K. TAKAHASHI, J. Neurochem. 61 1050-1056 (1993).
40. 40. M. TOTH and T. SHENK, Mol. Pharmacol. 45 1095-1100 (1994).
41. 41. R.C. FERRY, C.D. UNSWORTH and P.B. MOLINOFF, Mol. Pharmacol. 43 726-733 (1993).
42. 42. M.S. GROTEWIEL and E. SANDERS-BUSH, J. Neurochem. 63 1255-1260 (1994).
43. 43. A. KAGAYA, M. MIKUNI, I. KUSUMI, H. YAMAMOTO and K. TAKAHASHI, J. Pharmacol. Exp. Ther. 255 305-311 (1990).
44. 44. A. KAGAYA, N. MOTOHASHI, A. KUGAYA, T. YAMAJI, T. HAYASHI, Y. OKAMOTO, H. SHINNO, M. TAKEBAYASHI, Y. UCHITOMI and S. YAMAWAKI, J. Neural Transm. 100 27-38 (1995).
45. 45. R.C. FERRY, C.D. UNSWORTH, R.P. ARTYMYSHYN and P.B. MOLINOFF, J. Biol. Chem. 269 31850-31857 (1994).